You are here: Home: LCU 2 | 2006 : Case 6: Select publications

SELECT PUBLICATIONS

Baas P et al. Concurrent chemotherapy (carboplatin, paclitaxel, etoposide) and involvedfield radiotherapy in limited stage small cell lung cancer: A Dutch multicenter phase II study. Br J Cancer 2006;94(5):625-30. Abstract

Ciombor KK, Rocha Lima CM. Management of small cell lung cancer. Curr Treat Options Oncol 2006;7(1):59-68. Abstract

Edelman MJ et al. Phase II trial of cisplatin/etoposide and concurrent radiotherapy followed by paclitaxel/carboplatin consolidation for limited small-cell lung cancer: Southwest Oncology Group 9713. J Clin Oncol 2004;22(1):127-32. Abstract

Fukuda M et al. A phase I trial of carboplatin and etoposide for elderly (>/=75 year-old) patients with small-cell lung cancer. Cancer Chemother Pharmacol 2006;[Epub ahead of print]. Abstract

Hainsworth JD et al. Paclitaxel, carboplatin, and extended-schedule oral etoposide for small-cell lung cancer. Oncology (Williston Park) 1998;12(1 Suppl 2):31-5. Abstract

Hainsworth JD et al. Paclitaxel, carboplatin, and extended-schedule etoposide in the treatment of small-cell lung cancer: Comparison of sequential phase II trials using different dose-intensities. J Clin Oncol 1997;15(12):3464-70. Abstract

Jeremic B et al. Hyperfractionated radiation therapy and concurrent low-dose, daily carboplatin/etoposide with or without weekend carboplatin/etoposide chemotherapy in stage III non-small-cell lung cancer: A randomized trial. Int J Radiat Oncol Biol Phys 2001;50(1):19-25. Abstract

Jeremic B et al. Role of radiation therapy in the combined-modality treatment of patients with extensive disease small-cell lung cancer: A randomized study. J Clin Oncol 1999;17(7):2092-9. Abstract

Jeremic B et al. Hyperfractionated radiation therapy with or without concurrent low-dose daily carboplatin/etoposide for stage III non-small-cell lung cancer: A randomized study. J Clin Oncol 1996;14(4):1065-70. Abstract

Larive S et al; Groupe Lyon-Saint Etienne d’Oncologie Thoracique. Carboplatin-etoposide combination in small cell lung cancer patients older than 70 years: A phase II trial. Lung Cancer 2002;35(1):1-7. Abstract

Quoix E et al. Etoposide phosphate with carboplatin in the treatment of elderly patients with small-cell lung cancer: A phase II study. Ann Oncol 2001;12(7):957-62. Abstract

Schmittel A et al. A randomized phase II trial of irinotecan plus carboplatin versus etoposide plus carboplatin treatment in patients with extended disease small-cell lung cancer. Ann Oncol 2006;17(4):663-7. Abstract

Table of Contents

Top of Page